

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 7.08029349 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.08029349 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 6.70445506 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.70445506 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 5.92872707 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.76823659 |
| 7 | epoxygenase P450 pathway (GO:0019373) | 5.53595619 |
| 8 | exogenous drug catabolic process (GO:0042738) | 5.28194714 |
| 9 | high-density lipoprotein particle remodeling (GO:0034375) | 5.06585428 |
| 10 | alpha-linolenic acid metabolic process (GO:0036109) | 5.04603079 |
| 11 | bile acid biosynthetic process (GO:0006699) | 4.97538239 |
| 12 | tryptophan catabolic process (GO:0006569) | 4.92673226 |
| 13 | indole-containing compound catabolic process (GO:0042436) | 4.92673226 |
| 14 | indolalkylamine catabolic process (GO:0046218) | 4.92673226 |
| 15 | glyoxylate metabolic process (GO:0046487) | 4.84096092 |
| 16 | kynurenine metabolic process (GO:0070189) | 4.83423676 |
| 17 | tryptophan metabolic process (GO:0006568) | 4.82765538 |
| 18 | sulfur amino acid catabolic process (GO:0000098) | 4.78771185 |
| 19 | urea cycle (GO:0000050) | 4.72807659 |
| 20 | urea metabolic process (GO:0019627) | 4.72807659 |
| 21 | protein carboxylation (GO:0018214) | 4.66428475 |
| 22 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.66428475 |
| 23 | negative regulation of fibrinolysis (GO:0051918) | 4.63669865 |
| 24 | regulation of cholesterol esterification (GO:0010872) | 4.63156629 |
| 25 | tyrosine metabolic process (GO:0006570) | 4.59773423 |
| 26 | reverse cholesterol transport (GO:0043691) | 4.58002819 |
| 27 | cysteine metabolic process (GO:0006534) | 4.55892735 |
| 28 | aromatic amino acid family metabolic process (GO:0009072) | 4.51652820 |
| 29 | regulation of fibrinolysis (GO:0051917) | 4.50448036 |
| 30 | bile acid metabolic process (GO:0008206) | 4.38141024 |
| 31 | plasma lipoprotein particle remodeling (GO:0034369) | 4.37524740 |
| 32 | protein-lipid complex remodeling (GO:0034368) | 4.37524740 |
| 33 | macromolecular complex remodeling (GO:0034367) | 4.37524740 |
| 34 | nitrogen cycle metabolic process (GO:0071941) | 4.36298806 |
| 35 | complement activation, alternative pathway (GO:0006957) | 4.34134237 |
| 36 | phospholipid efflux (GO:0033700) | 4.34129149 |
| 37 | acylglycerol homeostasis (GO:0055090) | 4.31162138 |
| 38 | triglyceride homeostasis (GO:0070328) | 4.31162138 |
| 39 | omega-hydroxylase P450 pathway (GO:0097267) | 4.29756614 |
| 40 | regulation of triglyceride catabolic process (GO:0010896) | 4.28912400 |
| 41 | regulation of protein activation cascade (GO:2000257) | 4.27994204 |
| 42 | cellular ketone body metabolic process (GO:0046950) | 4.20865807 |
| 43 | blood coagulation, intrinsic pathway (GO:0007597) | 4.19362723 |
| 44 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.15331844 |
| 45 | lysine metabolic process (GO:0006553) | 4.15056362 |
| 46 | lysine catabolic process (GO:0006554) | 4.15056362 |
| 47 | serine family amino acid catabolic process (GO:0009071) | 4.10944787 |
| 48 | indolalkylamine metabolic process (GO:0006586) | 4.08799986 |
| 49 | homocysteine metabolic process (GO:0050667) | 4.05111740 |
| 50 | alpha-amino acid catabolic process (GO:1901606) | 4.04957154 |
| 51 | NADH metabolic process (GO:0006734) | 4.01053619 |
| 52 | amino-acid betaine metabolic process (GO:0006577) | 4.00970551 |
| 53 | negative regulation of sterol transport (GO:0032372) | 3.98286468 |
| 54 | negative regulation of cholesterol transport (GO:0032375) | 3.98286468 |
| 55 | regulation of complement activation (GO:0030449) | 3.97738402 |
| 56 | bile acid and bile salt transport (GO:0015721) | 3.96191368 |
| 57 | response to mercury ion (GO:0046689) | 3.94439894 |
| 58 | plasma lipoprotein particle clearance (GO:0034381) | 3.94282175 |
| 59 | cholesterol efflux (GO:0033344) | 3.90043226 |
| 60 | coenzyme catabolic process (GO:0009109) | 3.86932598 |
| 61 | ethanol metabolic process (GO:0006067) | 3.86688805 |
| 62 | cellular amino acid catabolic process (GO:0009063) | 3.82439890 |
| 63 | glutamate metabolic process (GO:0006536) | 3.75702192 |
| 64 | low-density lipoprotein particle remodeling (GO:0034374) | 3.73927171 |
| 65 | plasma lipoprotein particle assembly (GO:0034377) | 3.70888975 |
| 66 | short-chain fatty acid metabolic process (GO:0046459) | 3.69151671 |
| 67 | regulation of cholesterol homeostasis (GO:2000188) | 3.69030215 |
| 68 | cellular modified amino acid catabolic process (GO:0042219) | 3.65974993 |
| 69 | cellular glucuronidation (GO:0052695) | 3.64198732 |
| 70 | imidazole-containing compound metabolic process (GO:0052803) | 3.63150095 |
| 71 | ketone body metabolic process (GO:1902224) | 3.62478846 |
| 72 | drug catabolic process (GO:0042737) | 3.62243802 |
| 73 | intestinal cholesterol absorption (GO:0030299) | 3.57196919 |
| 74 | benzene-containing compound metabolic process (GO:0042537) | 3.54436648 |
| 75 | phenylpropanoid metabolic process (GO:0009698) | 3.48336683 |
| 76 | organic acid catabolic process (GO:0016054) | 3.47404553 |
| 77 | carboxylic acid catabolic process (GO:0046395) | 3.47404553 |
| 78 | fatty acid beta-oxidation (GO:0006635) | 3.45934132 |
| 79 | regulation of bile acid biosynthetic process (GO:0070857) | 3.43784372 |
| 80 | monocarboxylic acid catabolic process (GO:0072329) | 3.42703445 |
| 81 | positive regulation of lipid catabolic process (GO:0050996) | 3.41504657 |
| 82 | fatty acid oxidation (GO:0019395) | 3.40095802 |
| 83 | amine catabolic process (GO:0009310) | 3.40088131 |
| 84 | cellular biogenic amine catabolic process (GO:0042402) | 3.40088131 |
| 85 | negative regulation of lipase activity (GO:0060192) | 3.39004840 |
| 86 | plasma lipoprotein particle organization (GO:0071827) | 3.37865602 |
| 87 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.37183647 |
| 88 | lipoprotein metabolic process (GO:0042157) | 3.36712715 |
| 89 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.36407353 |
| 90 | phospholipid homeostasis (GO:0055091) | 3.36207722 |
| 91 | lipid oxidation (GO:0034440) | 3.35441271 |
| 92 | fatty acid catabolic process (GO:0009062) | 3.33354192 |
| 93 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.32506309 |
| 94 | ethanol oxidation (GO:0006069) | 3.31625514 |
| 95 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.30568923 |
| 96 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.30568923 |
| 97 | cholesterol homeostasis (GO:0042632) | 3.30522647 |
| 98 | aldehyde catabolic process (GO:0046185) | 3.30017827 |
| 99 | uronic acid metabolic process (GO:0006063) | 3.29608140 |
| 100 | glucuronate metabolic process (GO:0019585) | 3.29608140 |
| 101 | alkaloid metabolic process (GO:0009820) | 3.29535903 |
| 102 | protein activation cascade (GO:0072376) | 3.27649418 |
| 103 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.27603460 |
| 104 | protein-lipid complex assembly (GO:0065005) | 3.26267919 |
| 105 | creatine metabolic process (GO:0006600) | 3.25375741 |
| 106 | negative regulation of blood coagulation (GO:0030195) | 3.25359976 |
| 107 | negative regulation of hemostasis (GO:1900047) | 3.25359976 |
| 108 | drug metabolic process (GO:0017144) | 3.25316430 |
| 109 | sterol homeostasis (GO:0055092) | 3.24865508 |
| 110 | fibrinolysis (GO:0042730) | 3.24808850 |
| 111 | arginine metabolic process (GO:0006525) | 3.23821213 |
| 112 | aspartate family amino acid catabolic process (GO:0009068) | 3.23509977 |
| 113 | oxidative demethylation (GO:0070989) | 3.17892420 |
| 114 | complement activation, classical pathway (GO:0006958) | 3.12735048 |
| 115 | regulation of plasminogen activation (GO:0010755) | 3.10334024 |
| 116 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.07464315 |
| 117 | fructose metabolic process (GO:0006000) | 3.06390622 |
| 118 | complement activation (GO:0006956) | 3.02725897 |
| 119 | oxaloacetate metabolic process (GO:0006107) | 3.00733508 |
| 120 | negative regulation of protein activation cascade (GO:2000258) | 2.97610324 |
| 121 | negative regulation of coagulation (GO:0050819) | 2.94966450 |
| 122 | flavonoid metabolic process (GO:0009812) | 2.90858955 |
| 123 | hormone catabolic process (GO:0042447) | 2.89771662 |
| 124 | regulation of lipoprotein metabolic process (GO:0050746) | 2.89674205 |
| 125 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.87001299 |
| 126 | negative regulation of wound healing (GO:0061045) | 2.86358946 |
| 127 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.84146974 |
| 128 | acute-phase response (GO:0006953) | 2.77849421 |
| 129 | phosphate ion transmembrane transport (GO:0035435) | 2.77117089 |
| 130 | triglyceride catabolic process (GO:0019433) | 2.72796402 |
| 131 | neutral lipid catabolic process (GO:0046461) | 2.72639857 |
| 132 | acylglycerol catabolic process (GO:0046464) | 2.72639857 |
| 133 | primary alcohol catabolic process (GO:0034310) | 2.66730376 |
| 134 | negative regulation of complement activation (GO:0045916) | 2.66211145 |
| 135 | regulation of cholesterol metabolic process (GO:0090181) | 2.65700410 |
| 136 | positive regulation of hemostasis (GO:1900048) | 2.64890828 |
| 137 | positive regulation of blood coagulation (GO:0030194) | 2.64890828 |
| 138 | regulation of humoral immune response (GO:0002920) | 2.64593311 |
| 139 | regulation of apoptotic cell clearance (GO:2000425) | 2.63869779 |
| 140 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.61429875 |
| 141 | carnitine metabolic process (GO:0009437) | 2.60990014 |
| 142 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.55905353 |
| 143 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.51375022 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.38032020 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.27455365 |
| 3 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.88683114 |
| 4 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.62515209 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.93332057 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.35371161 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.33401939 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.68806325 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.25677089 |
| 10 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.79317130 |
| 11 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.20436451 |
| 12 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.13812268 |
| 13 | GATA1_22025678_ChIP-Seq_K562_Human | 2.02567155 |
| 14 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.1396905 |
| 15 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.99087941 |
| 16 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.79562274 |
| 17 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.78071289 |
| 18 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.75463057 |
| 19 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.75125532 |
| 20 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.62342951 |
| 21 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.61572513 |
| 22 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.57081847 |
| 23 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.56085161 |
| 24 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.55105285 |
| 25 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.49599169 |
| 26 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.33802442 |
| 27 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.30634362 |
| 28 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.29922151 |
| 29 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.29858609 |
| 30 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.29858609 |
| 31 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.25679485 |
| 32 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.25476948 |
| 33 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.25183476 |
| 34 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.24556689 |
| 35 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.20655157 |
| 36 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.19213388 |
| 37 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.15169396 |
| 38 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.14319040 |
| 39 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.13933828 |
| 40 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.13723632 |
| 41 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.10467291 |
| 42 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.09647719 |
| 43 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.09561704 |
| 44 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.07021950 |
| 45 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.06710072 |
| 46 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.06691223 |
| 47 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.05721598 |
| 48 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.98186146 |
| 49 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.96910265 |
| 50 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.95575073 |
| 51 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.95136953 |
| 52 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.95099023 |
| 53 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.93916841 |
| 54 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.93835327 |
| 55 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.92766688 |
| 56 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.91566401 |
| 57 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.91382662 |
| 58 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.91202593 |
| 59 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.90480288 |
| 60 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.90418027 |
| 61 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.90119228 |
| 62 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.90119228 |
| 63 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.89115499 |
| 64 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.88706021 |
| 65 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.87511783 |
| 66 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.85973452 |
| 67 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.85734868 |
| 68 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.85508356 |
| 69 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.84283149 |
| 70 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.84119304 |
| 71 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.84095335 |
| 72 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.83447634 |
| 73 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.83379472 |
| 74 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83234730 |
| 75 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.81641979 |
| 76 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.81125939 |
| 77 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.80974811 |
| 78 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.80962457 |
| 79 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.78841082 |
| 80 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.78104029 |
| 81 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.73919487 |
| 82 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.73526394 |
| 83 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.73308579 |
| 84 | AR_20517297_ChIP-Seq_VCAP_Human | 0.71633319 |
| 85 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.71336157 |
| 86 | KDM2B_26808549_Chip-Seq_K562_Human | 0.71101098 |
| 87 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.70913622 |
| 88 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.70184663 |
| 89 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.70024009 |
| 90 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.69644766 |
| 91 | GATA1_19941826_ChIP-Seq_K562_Human | 0.68760694 |
| 92 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.67233005 |
| 93 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.66933685 |
| 94 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.66420509 |
| 95 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.66292562 |
| 96 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.65919453 |
| 97 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.65431254 |
| 98 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.64705848 |
| 99 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.64562743 |
| 100 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.64414235 |
| 101 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.64061857 |
| 102 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.63731238 |
| 103 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.63352478 |
| 104 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.62963268 |
| 105 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.62525665 |
| 106 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.61983301 |
| 107 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.61553795 |
| 108 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.60800183 |
| 109 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.60559660 |
| 110 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.60440367 |
| 111 | CBP_21632823_ChIP-Seq_H3396_Human | 0.60283753 |
| 112 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.59345378 |
| 113 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.59112209 |
| 114 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.59029047 |
| 115 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.58525821 |
| 116 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.58000636 |
| 117 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.57253343 |
| 118 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.56569557 |
| 119 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.55534995 |
| 120 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.55409793 |
| 121 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.55228562 |
| 122 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.54512591 |
| 123 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.54157779 |
| 124 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.53460925 |
| 125 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.53079073 |
| 126 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.52885746 |
| 127 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.51888788 |
| 128 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.51623892 |
| 129 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.51553866 |
| 130 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.49558274 |
| 131 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.49503920 |
| 132 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.49176472 |
| 133 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.48954598 |
| 134 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.48390676 |
| 135 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.48390676 |
| 136 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.47937380 |
| 137 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 0.47804986 |
| 138 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.47368008 |
| 139 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.46611332 |
| 140 | GATA2_19941826_ChIP-Seq_K562_Human | 0.46406300 |
| 141 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.46289049 |
| 142 | * PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.46238546 |
| 143 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.46083011 |
| 144 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.45264978 |
| 145 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.45233154 |
| 146 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.44910482 |
| 147 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.43716434 |
| 148 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.43673886 |
| 149 | NCOR_22424771_ChIP-Seq_293T_Human | 0.43292416 |
| 150 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.43256125 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.58527301 |
| 2 | MP0005360_urolithiasis | 6.52403064 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.80816891 |
| 4 | MP0005365_abnormal_bile_salt | 5.76453854 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.62915488 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 3.82300996 |
| 7 | MP0003252_abnormal_bile_duct | 3.61272645 |
| 8 | MP0003195_calcinosis | 3.46730598 |
| 9 | MP0010329_abnormal_lipoprotein_level | 3.33974345 |
| 10 | MP0009840_abnormal_foam_cell | 3.14529223 |
| 11 | MP0005083_abnormal_biliary_tract | 2.88147953 |
| 12 | MP0005332_abnormal_amino_acid | 2.64054414 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.56212602 |
| 14 | MP0000751_myopathy | 2.52678209 |
| 15 | MP0002118_abnormal_lipid_homeostasis | 2.18160107 |
| 16 | MP0003879_abnormal_hair_cell | 2.03971412 |
| 17 | MP0000609_abnormal_liver_physiology | 1.97043666 |
| 18 | MP0004270_analgesia | 1.94829869 |
| 19 | MP0004215_abnormal_myocardial_fiber | 1.90651171 |
| 20 | MP0002138_abnormal_hepatobiliary_system | 1.90131917 |
| 21 | MP0004019_abnormal_vitamin_homeostasis | 1.89810624 |
| 22 | MP0003868_abnormal_feces_composition | 1.88977620 |
| 23 | MP0004036_abnormal_muscle_relaxation | 1.82257908 |
| 24 | MP0003191_abnormal_cellular_cholesterol | 1.81340181 |
| 25 | MP0002837_dystrophic_cardiac_calcinosis | 1.78911038 |
| 26 | MP0004084_abnormal_cardiac_muscle | 1.75263955 |
| 27 | MP0005167_abnormal_blood-brain_barrier | 1.60651695 |
| 28 | MP0005319_abnormal_enzyme/_coenzyme | 1.56827639 |
| 29 | MP0009780_abnormal_chondrocyte_physiolo | 1.53289387 |
| 30 | MP0004043_abnormal_pH_regulation | 1.53228951 |
| 31 | MP0002078_abnormal_glucose_homeostasis | 1.52073520 |
| 32 | * MP0009643_abnormal_urine_homeostasis | 1.49592846 |
| 33 | MP0001764_abnormal_homeostasis | 1.44854844 |
| 34 | MP0000749_muscle_degeneration | 1.44455520 |
| 35 | MP0005330_cardiomyopathy | 1.43527323 |
| 36 | MP0005220_abnormal_exocrine_pancreas | 1.38339819 |
| 37 | MP0009697_abnormal_copulation | 1.37982289 |
| 38 | MP0004859_abnormal_synaptic_plasticity | 1.37762809 |
| 39 | MP0006138_congestive_heart_failure | 1.36533261 |
| 40 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.36242798 |
| 41 | MP0001944_abnormal_pancreas_morphology | 1.34655490 |
| 42 | MP0002822_catalepsy | 1.33728777 |
| 43 | MP0001501_abnormal_sleep_pattern | 1.33358565 |
| 44 | MP0003646_muscle_fatigue | 1.33312755 |
| 45 | MP0002909_abnormal_adrenal_gland | 1.30371787 |
| 46 | MP0002693_abnormal_pancreas_physiology | 1.30296207 |
| 47 | MP0005379_endocrine/exocrine_gland_phen | 1.28597934 |
| 48 | MP0002064_seizures | 1.23769576 |
| 49 | MP0004145_abnormal_muscle_electrophysio | 1.22681336 |
| 50 | MP0005535_abnormal_body_temperature | 1.21313124 |
| 51 | MP0002972_abnormal_cardiac_muscle | 1.19628111 |
| 52 | MP0004087_abnormal_muscle_fiber | 1.15355359 |
| 53 | MP0005620_abnormal_muscle_contractility | 1.14853910 |
| 54 | MP0000747_muscle_weakness | 1.14156691 |
| 55 | MP0005646_abnormal_pituitary_gland | 1.12607253 |
| 56 | MP0005636_abnormal_mineral_homeostasis | 1.11179136 |
| 57 | MP0002332_abnormal_exercise_endurance | 1.10860529 |
| 58 | MP0000920_abnormal_myelination | 1.09480270 |
| 59 | MP0003283_abnormal_digestive_organ | 1.08897760 |
| 60 | MP0002877_abnormal_melanocyte_morpholog | 1.08543179 |
| 61 | MP0003186_abnormal_redox_activity | 1.06215151 |
| 62 | MP0000013_abnormal_adipose_tissue | 1.03483857 |
| 63 | MP0009745_abnormal_behavioral_response | 1.03114631 |
| 64 | MP0000604_amyloidosis | 1.02375956 |
| 65 | MP0005670_abnormal_white_adipose | 1.01652748 |
| 66 | MP0003635_abnormal_synaptic_transmissio | 1.00516099 |
| 67 | MP0010386_abnormal_urinary_bladder | 1.00303696 |
| 68 | MP0004510_myositis | 1.00283285 |
| 69 | MP0002876_abnormal_thyroid_physiology | 0.99916745 |
| 70 | MP0005408_hypopigmentation | 0.99253154 |
| 71 | MP0004484_altered_response_of | 0.98916680 |
| 72 | MP0002269_muscular_atrophy | 0.98473868 |
| 73 | MP0003329_amyloid_beta_deposits | 0.97510530 |
| 74 | MP0005409_darkened_coat_color | 0.96646874 |
| 75 | MP0003075_altered_response_to | 0.95197320 |
| 76 | MP0009642_abnormal_blood_homeostasis | 0.95066502 |
| 77 | MP0001756_abnormal_urination | 0.94980614 |
| 78 | MP0005451_abnormal_body_composition | 0.94676111 |
| 79 | MP0002272_abnormal_nervous_system | 0.94595224 |
| 80 | MP0003953_abnormal_hormone_level | 0.94407167 |
| 81 | MP0006036_abnormal_mitochondrial_physio | 0.93880053 |
| 82 | MP0000598_abnormal_liver_morphology | 0.93100271 |
| 83 | MP0003633_abnormal_nervous_system | 0.91338355 |
| 84 | MP0003656_abnormal_erythrocyte_physiolo | 0.90993582 |
| 85 | MP0002254_reproductive_system_inflammat | 0.90984858 |
| 86 | MP0001544_abnormal_cardiovascular_syste | 0.90957398 |
| 87 | MP0005385_cardiovascular_system_phenoty | 0.90957398 |
| 88 | MP0002971_abnormal_brown_adipose | 0.89622285 |
| 89 | MP0001486_abnormal_startle_reflex | 0.89249879 |
| 90 | MP0005448_abnormal_energy_balance | 0.88677899 |
| 91 | MP0003137_abnormal_impulse_conducting | 0.88243077 |
| 92 | MP0005334_abnormal_fat_pad | 0.87917079 |
| 93 | MP0003011_delayed_dark_adaptation | 0.87419247 |
| 94 | MP0005166_decreased_susceptibility_to | 0.87402018 |
| 95 | MP0002063_abnormal_learning/memory/cond | 0.86246547 |
| 96 | MP0004130_abnormal_muscle_cell | 0.85742898 |
| 97 | MP0000639_abnormal_adrenal_gland | 0.85279619 |
| 98 | MP0008775_abnormal_heart_ventricle | 0.85060337 |
| 99 | MP0009115_abnormal_fat_cell | 0.84787494 |
| 100 | MP0005423_abnormal_somatic_nervous | 0.84619487 |
| 101 | MP0008569_lethality_at_weaning | 0.84581447 |
| 102 | MP0002106_abnormal_muscle_physiology | 0.83626387 |
| 103 | MP0005084_abnormal_gallbladder_morpholo | 0.81182053 |
| 104 | MP0005647_abnormal_sex_gland | 0.80822054 |
| 105 | MP0001440_abnormal_grooming_behavior | 0.78886238 |
| 106 | MP0001661_extended_life_span | 0.77809016 |
| 107 | MP0002928_abnormal_bile_duct | 0.75934680 |
| 108 | MP0004264_abnormal_extraembryonic_tissu | 0.73969887 |
| 109 | MP0003631_nervous_system_phenotype | 0.73592768 |
| 110 | MP0005165_increased_susceptibility_to | 0.73114846 |
| 111 | MP0004085_abnormal_heartbeat | 0.72947717 |
| 112 | MP0000249_abnormal_blood_vessel | 0.72024905 |
| 113 | MP0002572_abnormal_emotion/affect_behav | 0.71610886 |
| 114 | MP0005369_muscle_phenotype | 0.71290523 |
| 115 | MP0009763_increased_sensitivity_to | 0.70342390 |
| 116 | MP0005376_homeostasis/metabolism_phenot | 0.68659316 |
| 117 | MP0000759_abnormal_skeletal_muscle | 0.68333902 |
| 118 | MP0010630_abnormal_cardiac_muscle | 0.68184594 |
| 119 | MP0001502_abnormal_circadian_rhythm | 0.67792770 |
| 120 | MP0010368_abnormal_lymphatic_system | 0.67358640 |
| 121 | MP0000230_abnormal_systemic_arterial | 0.67182867 |
| 122 | MP0001984_abnormal_olfaction | 0.66584244 |
| 123 | MP0000538_abnormal_urinary_bladder | 0.64118067 |
| 124 | MP0003183_abnormal_peptide_metabolism | 0.63971372 |
| 125 | MP0003690_abnormal_glial_cell | 0.63967562 |
| 126 | MP0005266_abnormal_metabolism | 0.62510258 |
| 127 | MP0009764_decreased_sensitivity_to | 0.61311497 |
| 128 | MP0008469_abnormal_protein_level | 0.59746508 |
| 129 | MP0001765_abnormal_ion_homeostasis | 0.59672073 |
| 130 | MP0005058_abnormal_lysosome_morphology | 0.58339597 |
| 131 | MP0005666_abnormal_adipose_tissue | 0.56120896 |
| 132 | MP0009765_abnormal_xenobiotic_induced | 0.54570586 |
| 133 | MP0002638_abnormal_pupillary_reflex | 0.54352558 |
| 134 | MP0004782_abnormal_surfactant_physiolog | 0.53436503 |
| 135 | MP0003705_abnormal_hypodermis_morpholog | 0.49895266 |
| 136 | MP0003959_abnormal_lean_body | 0.49279246 |
| 137 | MP0000678_abnormal_parathyroid_gland | 0.46889152 |
| 138 | MP0000003_abnormal_adipose_tissue | 0.46111631 |
| 139 | MP0003638_abnormal_response/metabolism_ | 0.45791446 |
| 140 | MP0009672_abnormal_birth_weight | 0.45702817 |
| 141 | MP0000462_abnormal_digestive_system | 0.45214286 |
| 142 | MP0002970_abnormal_white_adipose | 0.44598550 |
| 143 | MP0002090_abnormal_vision | 0.43628513 |
| 144 | MP0005375_adipose_tissue_phenotype | 0.42942549 |
| 145 | MP0000579_abnormal_nail_morphology | 0.42913501 |
| 146 | MP0008961_abnormal_basal_metabolism | 0.41609075 |
| 147 | MP0005187_abnormal_penis_morphology | 0.39584900 |
| 148 | MP0002168_other_aberrant_phenotype | 0.39531547 |
| 149 | MP0002136_abnormal_kidney_physiology | 0.36525686 |
| 150 | MP0006276_abnormal_autonomic_nervous | 0.36275734 |
| 151 | MP0003300_gastrointestinal_ulcer | 0.34903582 |
| 152 | MP0005248_abnormal_Harderian_gland | 0.34657924 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.36891624 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.24152848 |
| 3 | Hypoglycemic coma (HP:0001325) | 5.98166824 |
| 4 | Deep venous thrombosis (HP:0002625) | 5.92779049 |
| 5 | Xanthomatosis (HP:0000991) | 5.62910958 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 5.61703456 |
| 7 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.57139107 |
| 8 | Hypobetalipoproteinemia (HP:0003563) | 5.33464398 |
| 9 | Hypoglycemic seizures (HP:0002173) | 4.97531843 |
| 10 | Hyperinsulinemic hypoglycemia (HP:0000825) | 4.74617860 |
| 11 | Ketosis (HP:0001946) | 4.65404729 |
| 12 | Hyperlipoproteinemia (HP:0010980) | 4.65361945 |
| 13 | Ketoacidosis (HP:0001993) | 4.36872000 |
| 14 | Abnormality of the common coagulation pathway (HP:0010990) | 4.15193184 |
| 15 | Complement deficiency (HP:0004431) | 4.13786432 |
| 16 | Hypolipoproteinemia (HP:0010981) | 4.10766157 |
| 17 | Hyperammonemia (HP:0001987) | 4.02920717 |
| 18 | Abnormality of the intrinsic pathway (HP:0010989) | 4.01006433 |
| 19 | Epidermoid cyst (HP:0200040) | 3.94115218 |
| 20 | Conjugated hyperbilirubinemia (HP:0002908) | 3.92314306 |
| 21 | Hyperglycinemia (HP:0002154) | 3.89627803 |
| 22 | Symptomatic seizures (HP:0011145) | 3.87107557 |
| 23 | Joint hemorrhage (HP:0005261) | 3.83944105 |
| 24 | Hyperglycinuria (HP:0003108) | 3.81929516 |
| 25 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.71189121 |
| 26 | Hypoalphalipoproteinemia (HP:0003233) | 3.63843387 |
| 27 | Abnormality of glycine metabolism (HP:0010895) | 3.62522207 |
| 28 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.62522207 |
| 29 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.59667922 |
| 30 | Fat malabsorption (HP:0002630) | 3.59501200 |
| 31 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.49592374 |
| 32 | Exercise-induced myalgia (HP:0003738) | 3.45127386 |
| 33 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.45100404 |
| 34 | Abnormality of methionine metabolism (HP:0010901) | 3.39296830 |
| 35 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.31665692 |
| 36 | Late onset (HP:0003584) | 3.28091765 |
| 37 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.27068329 |
| 38 | Muscle fiber splitting (HP:0003555) | 3.26370783 |
| 39 | Hyperglycemia (HP:0003074) | 3.24432781 |
| 40 | Generalized aminoaciduria (HP:0002909) | 3.20652391 |
| 41 | Bundle branch block (HP:0011710) | 3.15321059 |
| 42 | Hyporeflexia of lower limbs (HP:0002600) | 3.14754927 |
| 43 | Hyperbilirubinemia (HP:0002904) | 3.11241966 |
| 44 | Sudden death (HP:0001699) | 3.09759270 |
| 45 | Atrioventricular block (HP:0001678) | 2.99168131 |
| 46 | Hypercholesterolemia (HP:0003124) | 2.97107994 |
| 47 | Skin nodule (HP:0200036) | 2.95371014 |
| 48 | Gout (HP:0001997) | 2.92839203 |
| 49 | Heart block (HP:0012722) | 2.92260325 |
| 50 | Nephritis (HP:0000123) | 2.92233917 |
| 51 | Abnormality of purine metabolism (HP:0004352) | 2.91971608 |
| 52 | Abnormality of complement system (HP:0005339) | 2.88400374 |
| 53 | Abnormality of nucleobase metabolism (HP:0010932) | 2.83284697 |
| 54 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.80840399 |
| 55 | Dicarboxylic aciduria (HP:0003215) | 2.80840399 |
| 56 | Abnormal atrioventricular conduction (HP:0005150) | 2.78595753 |
| 57 | Delayed CNS myelination (HP:0002188) | 2.73139671 |
| 58 | Metabolic acidosis (HP:0001942) | 2.69997149 |
| 59 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.65910874 |
| 60 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.65513559 |
| 61 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.65513559 |
| 62 | Muscle fiber inclusion bodies (HP:0100299) | 2.64414481 |
| 63 | Hemorrhage of the eye (HP:0011885) | 2.62193343 |
| 64 | Irritability (HP:0000737) | 2.56067404 |
| 65 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.51418844 |
| 66 | Abnormality of serum amino acid levels (HP:0003112) | 2.50147474 |
| 67 | Nemaline bodies (HP:0003798) | 2.49827440 |
| 68 | Abnormal gallbladder morphology (HP:0012437) | 2.46939340 |
| 69 | Lethargy (HP:0001254) | 2.46239836 |
| 70 | Steatorrhea (HP:0002570) | 2.44341376 |
| 71 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.42123836 |
| 72 | Type 1 muscle fiber predominance (HP:0003803) | 2.41221356 |
| 73 | EMG: myopathic abnormalities (HP:0003458) | 2.40788334 |
| 74 | Rhabdomyolysis (HP:0003201) | 2.38163471 |
| 75 | Hepatocellular carcinoma (HP:0001402) | 2.37254831 |
| 76 | Asymmetric septal hypertrophy (HP:0001670) | 2.35937565 |
| 77 | Exercise-induced muscle cramps (HP:0003710) | 2.30781645 |
| 78 | Cerebral edema (HP:0002181) | 2.30143311 |
| 79 | Enlarged kidneys (HP:0000105) | 2.29364253 |
| 80 | Ventricular tachycardia (HP:0004756) | 2.23616799 |
| 81 | Mitral stenosis (HP:0001718) | 2.23421190 |
| 82 | Brushfield spots (HP:0001088) | 2.23205977 |
| 83 | Spontaneous abortion (HP:0005268) | 2.21912002 |
| 84 | Syncope (HP:0001279) | 2.21891639 |
| 85 | Increased variability in muscle fiber diameter (HP:0003557) | 2.18420965 |
| 86 | Rickets (HP:0002748) | 2.16865101 |
| 87 | Abnormality of urine glucose concentration (HP:0011016) | 2.16714272 |
| 88 | Glycosuria (HP:0003076) | 2.16714272 |
| 89 | Myocardial infarction (HP:0001658) | 2.16310160 |
| 90 | Pancreatitis (HP:0001733) | 2.14621729 |
| 91 | Acanthocytosis (HP:0001927) | 2.12521253 |
| 92 | Action tremor (HP:0002345) | 2.12319863 |
| 93 | Sensorimotor neuropathy (HP:0007141) | 2.11520993 |
| 94 | Myokymia (HP:0002411) | 2.11099272 |
| 95 | Cholelithiasis (HP:0001081) | 2.10769207 |
| 96 | Purpura (HP:0000979) | 2.10420650 |
| 97 | Acute hepatic failure (HP:0006554) | 2.09954144 |
| 98 | Ventricular arrhythmia (HP:0004308) | 2.06864288 |
| 99 | Hypochromic microcytic anemia (HP:0004840) | 2.04837638 |
| 100 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.03913263 |
| 101 | Distal lower limb muscle weakness (HP:0009053) | 2.03460255 |
| 102 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.02413799 |
| 103 | Facial shape deformation (HP:0011334) | 2.01264354 |
| 104 | Potter facies (HP:0002009) | 2.01264354 |
| 105 | Atrial fibrillation (HP:0005110) | 2.01224255 |
| 106 | Vomiting (HP:0002013) | 2.00358763 |
| 107 | Abnormality of the calf musculature (HP:0001430) | 2.00239381 |
| 108 | Myoglobinuria (HP:0002913) | 1.99652865 |
| 109 | Glomerulonephritis (HP:0000099) | 1.98085052 |
| 110 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.97856545 |
| 111 | Alkalosis (HP:0001948) | 1.95625198 |
| 112 | Vascular calcification (HP:0004934) | 1.95612421 |
| 113 | Limb hypertonia (HP:0002509) | 1.95524336 |
| 114 | Malnutrition (HP:0004395) | 1.95474479 |
| 115 | Insulin resistance (HP:0000855) | 1.95421305 |
| 116 | Hydroxyprolinuria (HP:0003080) | 1.94515010 |
| 117 | Abnormality of proline metabolism (HP:0010907) | 1.94515010 |
| 118 | Amyloidosis (HP:0011034) | 1.94027555 |
| 119 | Renal cortical cysts (HP:0000803) | 1.93604326 |
| 120 | Systemic lupus erythematosus (HP:0002725) | 1.93169356 |
| 121 | Cholecystitis (HP:0001082) | 1.92484299 |
| 122 | Abnormal gallbladder physiology (HP:0012438) | 1.92484299 |
| 123 | Neonatal onset (HP:0003623) | 1.91880704 |
| 124 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.91689048 |
| 125 | Abnormality of the gallbladder (HP:0005264) | 1.91279006 |
| 126 | Right ventricular cardiomyopathy (HP:0011663) | 1.91263140 |
| 127 | Cardiovascular calcification (HP:0011915) | 1.90916385 |
| 128 | Menorrhagia (HP:0000132) | 1.89981199 |
| 129 | Difficulty running (HP:0009046) | 1.87225464 |
| 130 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.87106342 |
| 131 | Increased connective tissue (HP:0009025) | 1.86934853 |
| 132 | Neck muscle weakness (HP:0000467) | 1.85969123 |
| 133 | Dilated cardiomyopathy (HP:0001644) | 1.84346200 |
| 134 | Primary atrial arrhythmia (HP:0001692) | 1.83820094 |
| 135 | Foot dorsiflexor weakness (HP:0009027) | 1.83794416 |
| 136 | Abnormality of the foot musculature (HP:0001436) | 1.80472993 |
| 137 | Neurofibrillary tangles (HP:0002185) | 1.77593580 |
| 138 | Neonatal hypoglycemia (HP:0001998) | 1.77558388 |
| 139 | Calf muscle hypertrophy (HP:0008981) | 1.77510316 |
| 140 | Hyperuricemia (HP:0002149) | 1.77160666 |
| 141 | Increased purine levels (HP:0004368) | 1.77160666 |
| 142 | Abnormality of vitamin metabolism (HP:0100508) | 1.76577555 |
| 143 | Elevated alkaline phosphatase (HP:0003155) | 1.75900459 |
| 144 | Osteomalacia (HP:0002749) | 1.75546730 |
| 145 | Proximal tubulopathy (HP:0000114) | 1.75488066 |
| 146 | Retinal atrophy (HP:0001105) | 1.75224395 |
| 147 | Ventricular fibrillation (HP:0001663) | 1.74330157 |
| 148 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.73291399 |
| 149 | Abnormality of the Achilles tendon (HP:0005109) | 1.73022774 |
| 150 | Supraventricular tachycardia (HP:0004755) | 1.72438062 |
| 151 | Back pain (HP:0003418) | 1.70677503 |
| 152 | Pigmentary retinal degeneration (HP:0001146) | 1.70463055 |
| 153 | Lipoatrophy (HP:0100578) | 1.69853555 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | INSRR | 6.44472114 |
| 2 | BCKDK | 5.32133681 |
| 3 | ERN1 | 3.84581221 |
| 4 | SIK1 | 3.67565178 |
| 5 | MAPK15 | 3.64875596 |
| 6 | OBSCN | 3.24930002 |
| 7 | TAOK3 | 3.06636940 |
| 8 | FGFR4 | 3.02610533 |
| 9 | MYLK | 2.58268384 |
| 10 | FLT3 | 2.49387641 |
| 11 | TTN | 2.43524153 |
| 12 | PASK | 2.38259649 |
| 13 | FRK | 2.27477131 |
| 14 | MARK1 | 2.17818042 |
| 15 | NTRK1 | 2.00421014 |
| 16 | MAP3K2 | 1.89298488 |
| 17 | TRIB3 | 1.68308309 |
| 18 | MAPK12 | 1.61517310 |
| 19 | ERBB4 | 1.59877305 |
| 20 | DMPK | 1.56150681 |
| 21 | PIK3CG | 1.53767121 |
| 22 | UHMK1 | 1.48986168 |
| 23 | MAP2K4 | 1.47659352 |
| 24 | HIPK2 | 1.47440190 |
| 25 | MST1R | 1.39662951 |
| 26 | PTK6 | 1.33733600 |
| 27 | PRKD3 | 1.33187540 |
| 28 | MET | 1.33057670 |
| 29 | CAMK2B | 1.31677440 |
| 30 | PRPF4B | 1.29896130 |
| 31 | EPHA3 | 1.28614097 |
| 32 | PAK6 | 1.28411631 |
| 33 | LATS2 | 1.25628277 |
| 34 | MAPKAPK3 | 1.15978219 |
| 35 | PINK1 | 1.15912386 |
| 36 | DAPK2 | 1.13749924 |
| 37 | PTK2 | 1.09642382 |
| 38 | PIK3CA | 1.03903497 |
| 39 | MAPK11 | 0.99691105 |
| 40 | MAP3K1 | 0.99328787 |
| 41 | JAK2 | 0.98183784 |
| 42 | ROCK1 | 0.97714535 |
| 43 | WNK4 | 0.97057940 |
| 44 | IRAK3 | 0.96881719 |
| 45 | PKN2 | 0.95821359 |
| 46 | CAMK1 | 0.95252875 |
| 47 | MAP3K3 | 0.93661679 |
| 48 | DYRK1B | 0.93637666 |
| 49 | PAK3 | 0.92300499 |
| 50 | PRKAA2 | 0.92169747 |
| 51 | NTRK2 | 0.90557218 |
| 52 | WNK3 | 0.90260827 |
| 53 | ROCK2 | 0.90230032 |
| 54 | ICK | 0.88183885 |
| 55 | CAMK2A | 0.87353116 |
| 56 | PDGFRA | 0.86071232 |
| 57 | CDK5 | 0.82926582 |
| 58 | PRKACG | 0.81956068 |
| 59 | PRKG1 | 0.80134398 |
| 60 | IRAK1 | 0.80015431 |
| 61 | TESK1 | 0.79749838 |
| 62 | PKN1 | 0.79655981 |
| 63 | MAP2K2 | 0.79210405 |
| 64 | CASK | 0.78100526 |
| 65 | LATS1 | 0.77914283 |
| 66 | PRKAA1 | 0.77141003 |
| 67 | MAP3K6 | 0.75151952 |
| 68 | NEK6 | 0.73758010 |
| 69 | SGK1 | 0.72992702 |
| 70 | MAP2K1 | 0.72504093 |
| 71 | MUSK | 0.70717070 |
| 72 | FGFR2 | 0.69651472 |
| 73 | MAP2K6 | 0.69420089 |
| 74 | JAK1 | 0.69226937 |
| 75 | STK38 | 0.68804672 |
| 76 | DAPK3 | 0.68476858 |
| 77 | PDK1 | 0.67894361 |
| 78 | CAMK2G | 0.67201452 |
| 79 | RPS6KA3 | 0.65151990 |
| 80 | TRPM7 | 0.64731522 |
| 81 | PRKCH | 0.64290369 |
| 82 | EPHB1 | 0.63660220 |
| 83 | DDR2 | 0.62149984 |
| 84 | SGK494 | 0.61642773 |
| 85 | SGK223 | 0.61642773 |
| 86 | SGK3 | 0.61325901 |
| 87 | TYRO3 | 0.60210373 |
| 88 | PDK2 | 0.59616020 |
| 89 | ERBB2 | 0.59554394 |
| 90 | RET | 0.59247840 |
| 91 | CAMK4 | 0.58825912 |
| 92 | GSK3A | 0.58781107 |
| 93 | STK38L | 0.58358514 |
| 94 | MAPK7 | 0.57840768 |
| 95 | MARK2 | 0.57809185 |
| 96 | MAPK10 | 0.57456032 |
| 97 | MINK1 | 0.57171826 |
| 98 | ABL2 | 0.56401926 |
| 99 | MAP3K7 | 0.55203384 |
| 100 | TYK2 | 0.54546582 |
| 101 | GRK7 | 0.54471139 |
| 102 | PRKCZ | 0.54095660 |
| 103 | PRKCE | 0.54077004 |
| 104 | SGK2 | 0.54012590 |
| 105 | IGF1R | 0.52755433 |
| 106 | EEF2K | 0.51175168 |
| 107 | RIPK1 | 0.50736943 |
| 108 | LIMK1 | 0.50478142 |
| 109 | PRKCG | 0.50393417 |
| 110 | MAP3K9 | 0.49715033 |
| 111 | LMTK2 | 0.48868924 |
| 112 | CDC42BPA | 0.48465611 |
| 113 | CAMK1D | 0.48305285 |
| 114 | FER | 0.47087288 |
| 115 | PDPK1 | 0.46070175 |
| 116 | FGFR3 | 0.45563106 |
| 117 | CAMKK2 | 0.43888685 |
| 118 | NTRK3 | 0.42361497 |
| 119 | PRKACA | 0.41381492 |
| 120 | ARAF | 0.41064900 |
| 121 | TIE1 | 0.40737890 |
| 122 | CSNK1G2 | 0.40460345 |
| 123 | CSNK1G1 | 0.38741238 |
| 124 | KSR2 | 0.37650828 |
| 125 | MAPK4 | 0.37002479 |
| 126 | PRKCQ | 0.36588693 |
| 127 | PDK3 | 0.36349690 |
| 128 | PDK4 | 0.36349690 |
| 129 | NEK9 | 0.36178095 |
| 130 | EPHA4 | 0.35467691 |
| 131 | PRKD1 | 0.35151533 |
| 132 | PRKCA | 0.34998770 |
| 133 | AKT3 | 0.34754351 |
| 134 | IRAK2 | 0.34750157 |
| 135 | GRK5 | 0.34689919 |
| 136 | PHKG1 | 0.33376609 |
| 137 | PHKG2 | 0.33376609 |
| 138 | GRK1 | 0.33355553 |
| 139 | CAMK1G | 0.32830085 |
| 140 | CAMK2D | 0.32500012 |
| 141 | NLK | 0.32258692 |
| 142 | ITK | 0.31892301 |
| 143 | PRKG2 | 0.31841895 |
| 144 | CAMKK1 | 0.29669401 |
| 145 | CSK | 0.29657668 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.83822180 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.57320567 |
| 3 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.19162366 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.00506445 |
| 5 | * Tryptophan metabolism_Homo sapiens_hsa00380 | 2.80252841 |
| 6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.69440030 |
| 7 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.62390077 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.62204606 |
| 9 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.61773331 |
| 10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.54940094 |
| 11 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.40482739 |
| 12 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.37313573 |
| 13 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.34231088 |
| 14 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.26899024 |
| 15 | * Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.06264803 |
| 16 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.05463572 |
| 17 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.02894274 |
| 18 | * Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.98422074 |
| 19 | Peroxisome_Homo sapiens_hsa04146 | 1.97737184 |
| 20 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.96281473 |
| 21 | * Histidine metabolism_Homo sapiens_hsa00340 | 1.83030266 |
| 22 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.73852998 |
| 23 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.73545792 |
| 24 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.69681970 |
| 25 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.68801988 |
| 26 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.61889353 |
| 27 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.61427515 |
| 28 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.60341279 |
| 29 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.57554271 |
| 30 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.56680249 |
| 31 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.53314471 |
| 32 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.53149146 |
| 33 | Bile secretion_Homo sapiens_hsa04976 | 1.48036644 |
| 34 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.45450017 |
| 35 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.43941042 |
| 36 | * Tyrosine metabolism_Homo sapiens_hsa00350 | 1.42074626 |
| 37 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.40315435 |
| 38 | * Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.40028433 |
| 39 | Retinol metabolism_Homo sapiens_hsa00830 | 1.39143345 |
| 40 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.33821574 |
| 41 | ABC transporters_Homo sapiens_hsa02010 | 1.28011041 |
| 42 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.27170924 |
| 43 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.26143122 |
| 44 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.24765372 |
| 45 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.23270548 |
| 46 | Carbon metabolism_Homo sapiens_hsa01200 | 1.04123834 |
| 47 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.02776826 |
| 48 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.02645107 |
| 49 | Protein export_Homo sapiens_hsa03060 | 1.00263099 |
| 50 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.95259330 |
| 51 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.93650387 |
| 52 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.90775728 |
| 53 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.86261527 |
| 54 | * Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.85075634 |
| 55 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.79388842 |
| 56 | Lysine degradation_Homo sapiens_hsa00310 | 0.77154079 |
| 57 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.76371470 |
| 58 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.75801220 |
| 59 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.75478119 |
| 60 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.73473849 |
| 61 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.71200555 |
| 62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.71056691 |
| 63 | Renin secretion_Homo sapiens_hsa04924 | 0.68635363 |
| 64 | Sulfur relay system_Homo sapiens_hsa04122 | 0.62024791 |
| 65 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.61372191 |
| 66 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.59978386 |
| 67 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.59701817 |
| 68 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.59514321 |
| 69 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.59448023 |
| 70 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.58673079 |
| 71 | Galactose metabolism_Homo sapiens_hsa00052 | 0.57474567 |
| 72 | GABAergic synapse_Homo sapiens_hsa04727 | 0.55739693 |
| 73 | Mineral absorption_Homo sapiens_hsa04978 | 0.51498603 |
| 74 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.50450822 |
| 75 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.50180305 |
| 76 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.50149203 |
| 77 | Insulin secretion_Homo sapiens_hsa04911 | 0.50114260 |
| 78 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.50108515 |
| 79 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.48856297 |
| 80 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.48387601 |
| 81 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.48055213 |
| 82 | Long-term potentiation_Homo sapiens_hsa04720 | 0.45811301 |
| 83 | Circadian entrainment_Homo sapiens_hsa04713 | 0.45704345 |
| 84 | Insulin resistance_Homo sapiens_hsa04931 | 0.44979179 |
| 85 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.44655991 |
| 86 | Prion diseases_Homo sapiens_hsa05020 | 0.43583545 |
| 87 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.43069133 |
| 88 | * Amphetamine addiction_Homo sapiens_hsa05031 | 0.42607723 |
| 89 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.42108554 |
| 90 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.41638654 |
| 91 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.41301680 |
| 92 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.41220638 |
| 93 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.41037312 |
| 94 | Nicotine addiction_Homo sapiens_hsa05033 | 0.38711153 |
| 95 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.36546549 |
| 96 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.35615116 |
| 97 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.34989897 |
| 98 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.33935378 |
| 99 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.33792193 |
| 100 | * Serotonergic synapse_Homo sapiens_hsa04726 | 0.31168357 |
| 101 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.30539353 |
| 102 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.29700817 |
| 103 | Morphine addiction_Homo sapiens_hsa05032 | 0.29437765 |
| 104 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.29349252 |
| 105 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.27460473 |
| 106 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.27269549 |
| 107 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.22657403 |
| 108 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.20685234 |
| 109 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.16925817 |
| 110 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.12511133 |
| 111 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.11807525 |
| 112 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.11435485 |
| 113 | Circadian rhythm_Homo sapiens_hsa04710 | 0.10730683 |
| 114 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.10544948 |
| 115 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.09091471 |
| 116 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.07498903 |
| 117 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.06157569 |
| 118 | Lysosome_Homo sapiens_hsa04142 | 0.05107084 |
| 119 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.02509230 |
| 120 | * Cocaine addiction_Homo sapiens_hsa05030 | 0.01317659 |
| 121 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.00131928 |
| 122 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | -0.0486728 |
| 123 | Pancreatic secretion_Homo sapiens_hsa04972 | -0.0305996 |
| 124 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.0283127 |

